1型糖尿病低碳水化合物饮食相关研究进展

Research progress on low carbohydrate diet in type 1 diabetes

低碳水化合物饮食(LCD)作为1型糖尿病(T1DM)的辅助疗法,在近几年备受关注,但其确切的有效性和安全性尚无定论。有限的文献报道了LCD对控制T1DM患者血糖及其并发症,调节肠道菌群与自身免疫有重要作用。本文从LCD模式对血糖的控制、不良反应以及对肠道菌群调节等方面阐述了近年来与LCD相关的T1DM医学营养治疗的研究进展。

Low carbohydrate diet(LCD),as an adjunctive therapy of type 1 diabetes(T1DM),has attracted much attention in recent years,but its exact efficacy and safety have not yet been determined.Limited literature has reported that LCD plays an important role in controlling blood sugar and its complications in T1DM patients,regulating intestinal microbiota,and autoimmunity.This article elaborates on the research progress of T1DM medical nutritional therapy related to LCD mode in recent years,including its control of blood sugar,adverse reactions,and regulation of intestinal microbiota.